FEATURED NEWS

MATEC
October 31, 2019
Updates to section of Vaccine-Preventable Diseases in Children and Adolescents with HIV Infection October 25, 2019: Vaccine-Preventable Diseases in Children and Adolescents with HIV Infection: The Panel updated this section and the recommended immunization schedule to include new vaccines available for the prevention of meningococcal infection (MenACWY-D MORE
MATEC
October 23, 2019
Updates to Several Tables in the Adult and Adolescent Opportunistic Infections Guidelines October 22, 2019: The Panel updated the following tables in the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. The updates include information on new drugs added to the guidelines as well as information MORE
FDA
December 12, 2018
FDA approves TEMIXYS: New HIV Fixed Dose Drug Combination November 27, 2018: FDA recently approved TEMIXYS (lamivudine and tenofovir disoproxil fumarate) tablets, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg. TEMIXYS was approved based on two MORE
MATEC
December 12, 2018
GENVOYA renal labeling updates Click here to view full announcement with additional information (webpage) VIREAD HBV label updates (pediatrics) Click here to view full announcement with additional information (website)
MATEC
December 10, 2018
www.matec.info HIV News Alert Updated HHS Perinatal Antiretroviral Treatment Guidelines Released December 7, 2018: The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (the Panel) is pleased to announce the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant MORE